Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 1 1

Status

Completed 4Withdrawn 1Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Plasma cell 1Lymphoid 1

Conditions

Red Blood Cells Transfusion 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Multiple Myeloma 1Motor Activity 1Leukemia, Promyelocytic, Acute 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × Erythrocyte Transfusion × Clear all
NCT02086773 2019-01-24

Red Cell Transfusion Goals in Patients With Acute Leukemias

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Completed
90 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01237639 2016-10-12

TRIST

Ottawa Hospital Research Institute

Phase 3 Completed
300 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT00577096 2015-04-06

Effects of Exercise in Combination With Epoetin Alfa

University of Arkansas

Phase NA Completed
120 enrolled 16 charts
Plasma cell

Motor Activity, Multiple Myeloma

NCT01502215 2012-12-05

TRISOP

University of Sao Paulo

Phase 3 Completed
198 enrolled

Red Blood Cells Transfusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡